Plain-English translation of NCT06793098 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is looking for new blood markers — special proteins called ghrelin, kisspeptin, and zonulin — that might help doctors detect insulin resistance earlier in women with polycystic ovary syndrome (PCOS). The study will compare these protein levels in three groups: women with PCOS and insulin resistance, women with PCOS without insulin resistance, and women without PCOS. By finding these early warning signs, doctors may be able to help women manage PCOS before serious complications develop.
PCOS is a common hormonal condition that affects many women of reproductive age, and insulin resistance plays a major role in making symptoms worse and increasing the risk of heart disease and cancer. Current tests for detecting insulin resistance are either complicated or only identify the problem after it's already developed, so researchers are searching for simpler, more reliable markers that can catch the problem much earlier — before symptoms become serious.
You likely qualify if…
You likely don't qualify if…
You would visit the research center for blood tests, which researchers will analyze to measure the levels of three specific proteins in your blood. The study involves about 100 women total, divided into three comparison groups based on whether you have PCOS and whether you have insulin resistance. Beyond the blood draw, the specific visit schedule and any follow-up appointments would be explained to you when you enroll.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
Poland
Sponsor
Jagiellonian University
Enrollment target
~100 participants
Started
January 2025
Primary completion
December 2027
Age range
18 Years – 45 Years
Sex
Female only
Last updated on clinicaltrials.gov in March 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Iwona Gawron, Ph.D., M.D.
Jagiellonian University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.